# US Ovulation Inhibition Study in Obese Women

> **NCT00873483** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 173 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Ethinylestradiol/Gestodene (BAY86-5016)

## Key facts

- **NCT ID:** NCT00873483
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-30
- **Primary completion:** 2010-03-03
- **Final completion:** 2010-03-03
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873483, "US Ovulation Inhibition Study in Obese Women". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00873483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*